Reuters logo
BRIEF-Insys Therapeutics announces FDA final product label for Syndros
May 24, 2017 / 11:07 AM / 4 months ago

BRIEF-Insys Therapeutics announces FDA final product label for Syndros

May 24 (Reuters) - Insys Therapeutics Inc

* Announces FDA final product label for syndros

* Insys Therapeutics Inc says syndros is approved for use in treating anorexia associated with weight loss in patients with acquired immune deficiency syndrome

* Insys Therapeutics Inc says to launch syndros in August 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below